Yancu Hertzanu
Overview
Explore the profile of Yancu Hertzanu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
86
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu B, Cao P, Wang Y, Wang W, Tian S, Hertzanu Y, et al.
World J Gastroenterol
. 2020 Aug;
26(27):3929-3937.
PMID: 32774067
Background: Some patients with hepatolithiasis cannot tolerate surgery due to severe cardiac or pulmonary comorbidities, or cannot be endoscopically treated because of altered gastrointestinal anatomies. Aim: To propose a modified...
2.
Liu B, Wang Y, Tian S, Hertzanu Y, Zhao X, Li Y
Thorac Cancer
. 2020 Jan;
11(3):697-703.
PMID: 31995853
Background: Salvage treatments for recurrent NSCLC after first-line chemotherapy remain challenging. This study was conducted to evaluate the clinical value of microwave ablation (MWA) and iodine-125 brachytherapy, including overall survival...
3.
4.
Hertzanu Y, Ye X
J Cancer Res Ther
. 2018 Dec;
14(7):1453-1454.
PMID: 30589022
No abstract available.
5.
Liu B, Wu D, Cao P, Wang Y, Wang W, Wang W, et al.
World J Gastroenterol
. 2018 Sep;
24(33):3799-3805.
PMID: 30197485
Aim: To evaluate the clinical efficacy and safety of an innovative percutaneous transhepatic extraction and balloon dilation (PTEBD) technique for clearance of gallbladder stones in patients with concomitant stones in...
6.
Liu B, Li Y, Wang Y, Wang W, Wang L, Hertzanu Y, et al.
Asia Pac J Clin Oncol
. 2016 Sep;
13(3):219-225.
PMID: 27682313
Aim: Certain metastasis-containing middle mediastinal lymph nodes cannot be approached by standard CT-guided brachytherapy. We here describe a novel trans-superior vena cava approach for such nodes. The aim of this...
7.
Zhao M, Liu B, Li S, Wang Y, Li Y, Hertzanu Y
Chin Med J (Engl)
. 2015 Apr;
128(8):1079-83.
PMID: 25881603
Background: Percutaneous brachytherapy is a valuable method for the treatment of lung cancer and mediastinal lymph nodes metastasis. However, in some of the metastatic lymph nodes in the middle mediastinum,...
8.
Hu H, Duan Z, Long X, Hertzanu Y, Tong X, Xu X, et al.
PLoS One
. 2015 Feb;
10(2):e0117168.
PMID: 25689846
Aims: This retrospective study was carried out to compare the outcomes between elderly (≥70 years of age) and nonelderly patients (<70 years of age) with advanced hepatocellular carcinoma (HCC) who...
9.
Hu H, Duan Z, Long X, Hertzanu Y, Shi H, Liu S, et al.
PLoS One
. 2014 May;
9(5):e96620.
PMID: 24817002
Aims: The purpose of the present study was to compare the efficacies of transarterial chemoembolization (TACE) combined with sorafenib versus TACE monotherapy for treating patients with advanced hepatocellular carcinoma (HCC)....
10.
Zeller L, Etzion Y, Hertzanu Y, Schlaeffer F, Sukenik S
Isr Med Assoc J
. 2008 Oct;
10(8-9):655-6.
PMID: 18847174
No abstract available.